|
Etretinate (Tegison®) is a medication used to treat severe psoriasis. It was removed from the US market in 1998 and the Canadian market in 1996, due to the high risk of birth defects.
Precautions Side effects | ||||||||
|
| |||||||||
 |
|
| |
|
Etretinate (Tegison®) is a medication used to treat severe psoriasis. It was removed from the US market in 1998 and the Canadian market in 1996, due to the high risk of birth defects.
Precautions Side effects | ||||||||
|
| |||||||||
|
|
|
| |